This inventor holds 2 USPTO granted patents. Top assignee: Merck + Co., Inc.. Active years: 2002-2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002-2003
Title: Inventor Spotlight: Ravi N. Guthikonda
Introduction: Ravi N. Guthikonda, based in Edison, NJ, is an innovative figure in the pharmaceutical industry known for his contributions to the field of chemokine receptor modulation. With two patents to his name, his work continues to influence the development of new therapeutic strategies.
Latest Patents: Ravi's cutting-edge research has led to his latest patents, specifically focusing on “N-cyclopentyl modulators of chemokine receptor activity.” These patents showcase his commitment to advancing medical science and improving patient outcomes through targeted therapies.
Career Highlights: Currently employed at Merck & Company, Inc., Ravi utilizes his expertise to drive research initiatives that align with the company's mission to discover and develop innovative medicines. His work at Merck has positioned him as a valuable asset in the quest for new treatments.
Collaborations: Ravi has collaborated with esteemed colleagues in his field, including Paul E. Finke and Kerry A. Hilfiker. These professional partnerships underscore the collaborative nature of research and innovation within the pharmaceutical industry.
Conclusion: As an inventor, Ravi N. Guthikonda exemplifies the spirit of innovation in the healthcare sector. With his significant contributions and ongoing research, he continues to pave the way for advancements that have the potential to transform patient care and therapeutic approaches.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile